FDA approves first new drug for lupus in 56 years
WASHINGTON (AP) - March 9, 2011 (WPVI) -- The Food and Drug Administration has approved the first new drug to treat lupus since 1955, a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating illness.
Known as Benlysta, the injectable drug is designed to treat flare-ups and pain caused by lupus, a little-understood disorder in which the body attacks its own tissue and organs.
Biotech drugmaker Human Genome Sciences spent 15 years developing Benlysta and will co-market it with GlaxoSmithKline.
But experts stress that Benlysta is not a miracle drug: It only worked in a subset of patients and was not effective against the deadliest forms of the disease. Additionally, it did not work in African Americans, who are disproportionately affected by lupus.
- Malaysian leader: plane's disappearance deliberate
- Breezy And Mild!
- Get the 6abc StormTracker app
- WATCH: Action News Online
- 2 couples robbed at gunpoint in North Philly
- Fire forces 11 people from their homes
- Driver crashes SUV into pole in East Falls, DUI suspected
- Renovation competitors fight at Phila. fire scenes
- Moving day for Oak Lane Garden residents
- SEPTA union agrees to delay strike 49 min ago
- 100 plus weight loss journey to healthy living
- Boyd Theatre to be demolished, rebuilt
- Runway reopens after failed takeoff at PHL
- Photos: Suspects wanted by Philadelphia Police
Most Viewed StoriesMost Viewed Photos